How a Barcelona Post-Acute Facility became a Referral Center for Comprehensive Management of Subacute Patients With COVID-19.


Journal

Journal of the American Medical Directors Association
ISSN: 1538-9375
Titre abrégé: J Am Med Dir Assoc
Pays: United States
ID NLM: 100893243

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 08 05 2020
revised: 09 06 2020
accepted: 09 06 2020
entrez: 18 7 2020
pubmed: 18 7 2020
medline: 31 7 2020
Statut: ppublish

Résumé

The COVID-19 pandemic's greatest impact is among older adults. Management of the situation requires a systemic response, and post-acute care (PAC) can provide an adequate mix of active treatment, management of associated geriatric syndromes and palliative care, both in the acute phase, and in post-COVID-19 recovery. In the region of Catalonia, Spain, selected PAC centers have become sites to treat older patients with COVID-19. Referrals come from the emergency department or COVID-19 wards of the acute reference hospitals, nursing homes, or private homes. We critically review the actions taken by Parc Sanitari Pere Virgili, a PAC facility in Barcelona, to manage the pandemic, including its administration, health care, communication, psychological support, and ethical frameworks. We believe that the strategies we used and the lessons we learned can be useful for other sites and countries where similar adaptation of existing facilities may be implemented.

Identifiants

pubmed: 32674827
pii: S1525-8610(20)30520-X
doi: 10.1016/j.jamda.2020.06.015
pmc: PMC7287444
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

954-957

Informations de copyright

Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Références

Age Ageing. 2017 Nov 1;46(6):925-931
pubmed: 28655169
J Am Geriatr Soc. 2020 May;68(5):926-929
pubmed: 32255507
Osong Public Health Res Perspect. 2020 Apr;11(2):74-80
pubmed: 32257772
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
JAMA. 2020 May 26;323(20):2007-2008
pubmed: 32211831
J Am Med Dir Assoc. 2020 Jul;21(7):980-981
pubmed: 32563754
Cochrane Database Syst Rev. 2017 Sep 12;9:CD006211
pubmed: 28898390
J Am Med Dir Assoc. 2020 Jul;21(7):937-938
pubmed: 32674823
PLoS One. 2016 Nov 9;11(11):e0166304
pubmed: 27829011
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
J Am Med Dir Assoc. 2020 May;21(5):576-577
pubmed: 32334771
N Engl J Med. 2020 Jul 2;383(1):4-6
pubmed: 32267649
J Am Med Dir Assoc. 2015 Oct 1;16(10):837-41
pubmed: 26027719
J Am Med Dir Assoc. 2020 Jul;21(7):888-892
pubmed: 32674814
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
J Am Geriatr Soc. 1995 May;43(5):553-62
pubmed: 7537289
Psychiatry Res. 2020 May;287:112915
pubmed: 32199182
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
J Am Geriatr Soc. 2020 May;68(5):912-917
pubmed: 32212386
JAMA Intern Med. 2019 Jan 1;179(1):28-36
pubmed: 30419096
J Pain Symptom Manage. 2016 Jul;52(1):92-9
pubmed: 27233146
J Nutr Health Aging. 2020;24(4):364-365
pubmed: 32242202
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
J Am Med Dir Assoc. 2019 Feb;20(2):152-158.e2
pubmed: 30270027
Rev Esp Geriatr Gerontol. 2017 Mar - Apr;52(2):75-79
pubmed: 26948303
Dement Geriatr Cogn Disord. 2018;45(1-2):121-129
pubmed: 29723848

Auteurs

Marco Inzitari (M)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Universitat Autonoma de Barcelona, Barcelona, Spain. Electronic address: minzitari@perevirgili.cat.

Cristina Udina (C)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Universitat Autonoma de Barcelona, Barcelona, Spain.

Oscar Len (O)

Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Joan Ars (J)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Universitat Autonoma de Barcelona, Barcelona, Spain.

Cristina Arnal (C)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Universitat Autonoma de Barcelona, Barcelona, Spain.

Hugo Badani (H)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Vanessa Davey (V)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Ester Risco (E)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Pere Ayats (P)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Ana M de Andrés (AM)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Cristina Mayordomo (C)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Francisco J Ros (FJ)

Medical Oncology Department, Vall d'Hebron University Hospital and, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Alessandro Morandi (A)

Research Group on Aging, Frailty and Care Transitions in Barcelona, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; Ospedale Le Ancelle, Fondazione Teresa Camplani, Cremona, Italy.

Matteo Cesari (M)

Università Statale and Policlinico Maggiore, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH